News

The latest press releases, publications, and events for Innoviva Specialty Therapeutics

Filter by:

All News Press Releases Events

05.21.2025

Evaluation of Angiotensin II in Patients With Catecholamine-Resistant Vasodilatory Shock Requiring Continuous Renal Replacement Therapy (ANGEL CRRT)

Read More

05.21.2025

Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery

Read More

05.05.2025

A Prospective double-blind, randomised controlled trial comparing angiotensin II to norepinephrine to reduce length of hospital stay in cardiac surgery patients (the PORTHOS study protocol)

Read More

05.05.2025

ANGIOTENSIN II FOR CATECHOLAMINE-RESISTANT VASODILATORY SHOCK IN PATIENTS WITH ACUTE KIDNEY INJURY: A POST HOC ANALYSIS OF THE ATHOS-3 TRIAL

Read More

03.12.2025

ATHOS-3 Investigators. An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock

Read More

12.19.2024

Angiotensin II for catecholamine-resistant vasodilatory shock in patients with acute kidney injury: A post hoc analysis of the ATHOS-3 Trial

Read More

12.16.2024

The renin–angiotensin–aldosterone‑system in sepsis and its clinical modulation with exogenous angiotensin II

Read More

04.11.2024

A Pilot Study of Renin-Guided Angiotensin-II Infusion to Reduce Kidney Stress After Cardiac Surgery

Read More

04.11.2024

Clinical Response to Third-Line Angiotensin-II vs Epinephrine in Septic Shock: A Propensity-Matched Cohort Study

Read More

04.11.2024

Renin as a Prognostic Marker in Intensive Care and Perioperative Settings: A Scoping Review

Read More